A Double Blind Placebo Controlled Multi Centre Clinical Trial to Investigate the Efficacy and Safety of 12 Months of Therapy with Inhaled Colistimethate Sodium in the Treatment of Subjects with Non-Cystic Fibrosis Bronchiectasis